Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 140Leukemia, Myeloid, Acute 120Leukemia 98Precursor Cell Lymphoblastic Leukemia-Lymphoma 85Myeloproliferative Disorders 57Lymphoma 56Lymphoma, Non-Hodgkin 55Leukemia, Lymphocytic, Chronic, B-Cell 53Leukemia, Myeloid, Chronic-Phase 52Multiple Myeloma 51Leukemia, Myelomonocytic, Chronic 50Hodgkin Disease 49Congenital Abnormalities 47Leukemia, Myeloid, Accelerated Phase 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Primary Myelofibrosis 40Blast Crisis 39Anemia, Refractory, with Excess of Blasts 38Lymphoma, Follicular 37Lymphoma, Large B-Cell, Diffuse 36Lymphoma, Mantle-Cell 35Burkitt Lymphoma 35Myelodysplastic-Myeloproliferative Diseases 34Lymphoma, B-Cell, Marginal Zone 33Neoplasms, Plasma Cell 32Lymphoma, Large-Cell, Immunoblastic 31Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 31Graft vs Host Disease 24Dendritic Cell Sarcoma, Interdigitating 23Polycythemia Vera 21

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Melphalan 1Cyclophosphamide 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolism, Inborn Errors × Busulfan × Myeloid × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡